Tumor mutation burden: from comprehensive mutational screening to the clinic

The recent advent of immunomodulatory therapies into the clinic has demanded the identification of innovative predictive biomarkers to identify patients most likely to respond to immunotherapy and support the design of tailored clinical trials. Current molecular testing for selection of patients wit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Cell Int
Asıl Yazarlar: Galuppini, Francesca, Dal Pozzo, Carlo Alberto, Deckert, Jutta, Loupakis, Fotios, Fassan, Matteo, Baffa, Raffaele
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Minireview
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6686509/
https://ncbi.nlm.nih.gov/pubmed/31406485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-0929-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller